These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
8. Neuropathological and biochemical criteria to identify acquired Creutzfeldt-Jakob disease among presumed sporadic cases. Kobayashi A; Parchi P; Yamada M; Mohri S; Kitamoto T Neuropathology; 2016 Jun; 36(3):305-10. PubMed ID: 26669818 [TBL] [Abstract][Full Text] [Related]
9. Iatrogenic Creutzfeldt-Jakob disease with Amyloid-β pathology: an international study. Cali I; Cohen ML; Haik S; Parchi P; Giaccone G; Collins SJ; Kofskey D; Wang H; McLean CA; Brandel JP; Privat N; Sazdovitch V; Duyckaerts C; Kitamoto T; Belay ED; Maddox RA; Tagliavini F; Pocchiari M; Leschek E; Appleby BS; Safar JG; Schonberger LB; Gambetti P Acta Neuropathol Commun; 2018 Jan; 6(1):5. PubMed ID: 29310723 [TBL] [Abstract][Full Text] [Related]
10. Prion Strain Characterization of a Novel Subtype of Creutzfeldt-Jakob Disease. Galeno R; Di Bari MA; Nonno R; Cardone F; Sbriccoli M; Graziano S; Ingrosso L; Fiorini M; Valanzano A; Pasini G; Poleggi A; Vinci R; Ladogana A; Puopolo M; Monaco S; Agrimi U; Zanusso G; Pocchiari M J Virol; 2017 Jun; 91(11):. PubMed ID: 28298604 [TBL] [Abstract][Full Text] [Related]
11. Transmission properties of atypical Creutzfeldt-Jakob disease: a clue to disease etiology? Kobayashi A; Parchi P; Yamada M; Brown P; Saverioni D; Matsuura Y; Takeuchi A; Mohri S; Kitamoto T J Virol; 2015 Apr; 89(7):3939-46. PubMed ID: 25609817 [TBL] [Abstract][Full Text] [Related]
12. The Distribution of Prion Protein Allotypes Differs Between Sporadic and Iatrogenic Creutzfeldt-Jakob Disease Patients. Moore RA; Head MW; Ironside JW; Ritchie DL; Zanusso G; Choi YP; Priola SA PLoS Pathog; 2016 Feb; 12(2):e1005416. PubMed ID: 26840342 [TBL] [Abstract][Full Text] [Related]
13. The French surveillance network of Creutzfeldt-Jakob disease. Epidemiological data in France and worldwide. Brandel JP; Peckeu L; Haïk S Transfus Clin Biol; 2013 Sep; 20(4):395-7. PubMed ID: 23587616 [TBL] [Abstract][Full Text] [Related]
14. Agent strain variation in human prion disease: insights from a molecular and pathological review of the National Institutes of Health series of experimentally transmitted disease. Parchi P; Cescatti M; Notari S; Schulz-Schaeffer WJ; Capellari S; Giese A; Zou WQ; Kretzschmar H; Ghetti B; Brown P Brain; 2010 Oct; 133(10):3030-42. PubMed ID: 20823086 [TBL] [Abstract][Full Text] [Related]
15. Similar genetic susceptibility in iatrogenic and sporadic Creutzfeldt-Jakob disease. Deslys JP; Marcé D; Dormont D J Gen Virol; 1994 Jan; 75 ( Pt 1)():23-7. PubMed ID: 8113733 [TBL] [Abstract][Full Text] [Related]
16. Neuropathology of iatrogenic Creutzfeldt-Jakob disease and immunoassay of French cadaver-sourced growth hormone batches suggest possible transmission of tauopathy and long incubation periods for the transmission of Abeta pathology. Duyckaerts C; Sazdovitch V; Ando K; Seilhean D; Privat N; Yilmaz Z; Peckeu L; Amar E; Comoy E; Maceski A; Lehmann S; Brion JP; Brandel JP; Haïk S Acta Neuropathol; 2018 Feb; 135(2):201-212. PubMed ID: 29209767 [TBL] [Abstract][Full Text] [Related]
17. Prion protein heterogeneity in sporadic but not variant Creutzfeldt-Jakob disease: UK cases 1991-2002. Head MW; Bunn TJ; Bishop MT; McLoughlin V; Lowrie S; McKimmie CS; Williams MC; McCardle L; MacKenzie J; Knight R; Will RG; Ironside JW Ann Neurol; 2004 Jun; 55(6):851-9. PubMed ID: 15174020 [TBL] [Abstract][Full Text] [Related]